Buy PW Medtech for 3x upside in the long term with strong fundamentals. Added spice is the technicals support with William %R being in the oversold category!!
Trade aktif:
More BUY signals! CBPO 3Q results were mindblowing!: Company's key subsidiary CBPO has reported blockbuster 3Q results: Revenue and Operating earnings went up 14% YoY and 85% YoY, respectively. This will be reported on PW Medtech's Net profit on next earning season! On annual basis, this is around US$37m annualized NP for PW Medtech. Company also made some sales of CBPO shares with total proceeds at US$101mn so it's net cash would be US$31M. Plus the company itself makes around US$6mn in annual OP. So, let's just say we are only going to count CBPO value (14% stake in listed CBPO stock) & US$31m in cash and giving 0 value to the parentco company.
CBPO's market cap is US$4.4B and 13.9% of this equals $642m. This added with cash is US$673m.Let's say we give around 30% discount on this value which is US$436M. This is still 70% higher than current market price!!! Continue buying!
CBPO's market cap is US$4.4B and 13.9% of this equals $642m. This added with cash is US$673m.Let's say we give around 30% discount on this value which is US$436M. This is still 70% higher than current market price!!! Continue buying!